[ad_1] Statement from Susan C. Taylor, MD, FAAD, President, American Academy of Dermatology ROSEMONT, Ill., Dec. 11, 2025 /PRNewswire/ — The American Academy of Dermatology Association applauds the Food and Drug Administration for taking the […]
Tag: FDA Approval
Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025
[ad_1] HONG KONG, Dec. 10, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific […]
Die Fondazione Telethon gibt die FDA-Zulassung von Waskyra™ (Etuvetidigene Autotemcel) bekannt, einer Gentherapie zur Behandlung des Wiskott-Aldrich-Syndroms USA – Deutsch USA – English USA – English Italia – Italiano USA – Français USA – español
[ad_1] WAS betrifft fast ausschließlich Männer, mit einer geschätzten Inzidenz von 1 zu 250.000 Lebensgeburten männlicher Kinder. Die Therapie stellt eine große wissenschaftliche und klinische Errungenschaft dar und gibt den betroffenen Patienten neue Hoffnung. ROM, […]
FDA Approves the ProVee System
[ad_1] DUBLIN, Dec. 9, 2025 /PRNewswire/ — ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it has received FDA approval for its […]
Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia
[ad_1] CRENESSITY, the first new treatment available in 70 years to the classic congenital adrenal hyperplasia (CAH) community, offers a paradigm-shifting treatment approach FDA approval supported by data from the largest-ever clinical trial program in […]
